Global Healthcare Opportunities (GHO), a European specialist investor in healthcare, and Partners Group, a global

Drug development firm CatSci has secured £4.5 million of investment from ‘alternative lender’ Boost &

CDMO CordenPharma is planning to invest heavily in all its platforms in terms of both

At its virtual capital markets day on 9 September, Merck KGaA announced that it aims

During its 2020 results presentation, Italian API producer Olon announced the completion of a large-scale

Small molecule CDMO Cambrex is to spend $3.6 million to increase flexible drug substance manufacturing

Following on from recent investments at other group sites, WeylChem has announced plans to spend